A study published in JAMA Ophthalmology (2024) found that individuals using semaglutide had a 4.28-fold increase in the risk of NAION compared to other diabetic medications (Moss et al., 2024)
I look like myself Ever since seventh grade, Reva Stout has wanted to change her dark brown eyes to get a different look
Spencer Nadolsky is an obesity and lipid specialist and founder of Vineyard Health Melynda Barnes, MD is a board-certified facial plastic surgeon and obesity medicine specialist and chief medical officer at Ro Sonia Gibson, MD is a board-certified endocrinologist and physician lead at Allara Health Who Is a Good Candidate for the GLP-1 Pill
Encourages fat breakdown during fasting
Carbonated beverages can increase bloating
Exendin-4 shares approximately 53% structural similarity with human GLP-1 but is resistant to DPP-4 enzyme degradation, giving it a significantly longer half-life than native human GLP-1, which breaks down in approximately 2 minutes